The Use of New Agents and Their Roles in the Management, Control, and Prevention of Type 2 Diabetes
Pharmacologic therapy of type 2 diabetes has changed dramatically in the last 10 years, with new drugs and drug classes becoming available. These drugs allow for the use of combination oral therapy, often with improvement in glycemic control that was previously beyond the reach of medical therapy. Early initiation of pharmacologic therapy is associated with improved glycemic control and reduced long-term complications in type 2 diabetes. This session will outline the use of new agents available for patient diabetes and the roles these new agents play in the management of type 2 diabetes.
At the end of this educational activity, participants should be able to
- List drug classes used for the treatment of type 2 diabetes
- Discuss the treatment of type 2 diabetes with combinations of drugs and insulin
- Review the American Diabetes Association (ADA) guidelines for pharmacologic therapy for type 2 diabetes
Richard Bergenstal, MD
International Diabetes Center
Disclosures of Relevant Financial Relationships
In accordance with the ACCME Standards for Commercial SupportSM, OptumHealth Education requires all those involved in the development of activity content to disclose their relevant financial relationships. An individual has a relevant financial relationship if such person (or their spouse/partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.
OptumHealth Education ensures that the content is independent of commercial bias.
Richard Bergenstal, MD has reported the following:
Advisory Board, Consultant and Grant/Research Support:
Boehringer Ingelheim, Bristol-Myers Squibb/Astrazeneca, Eli Lilly, Halozyme, Inc., Johnson & Johnson, Novo Nordisk, Roche and Sanofi
Stocks and Other Ownership Interests: Merck
Sarah Chart-Hart, RN
Rebecca Gleason, RN, CCM
Martha L. New, BSN, RN, CCTC
Transplant Case Coordinator
Arlene Rome, RN, BSN
Anne M. Sendaydiego, PharmD
AMS Consulting, LLC
V. Silverstein, MD
Eagle Creek Medical Communications
Durham, North Carolina
Activity Planner Disclosures
Ms Chart, Ms Gleason, Ms New and Ms Rome have indicated that they are employees of and own stock in UnitedHealth Group.
Drs Sendaydiego and Silverstein have indicated that they have no relevant financial relationships.
Method of Participation
There are no fees for participating in or receiving credit for this activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Participants will receive a certificate upon successful completion of the activity, which includes the following:
- Completing the entire activity
- Completing the Pre- and Post-Activity Assessments, Activity Evaluation, and Application for Certificate of Credit forms
You must be logged into your account to participate in this activity. Get started by clicking “Begin” and viewing the “CE Info”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save, or print your certificate of participation. The Area of Practice you indicated in your profile corresponds with your certificate type. A complete listing of all of your activities can be found under “My Account”, “My Activities.”
OptumHealth Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statements
OptumHealth Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.
The participant will be awarded up to 0.75 contact hour(s) of credit for attendance and completion of supplemental materials.
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
Please note: In accordance with the CCMC policy, learners are required to take a minimum of one full hour (60 minutes) of continuing education (CE) from the activity: “24th Annual National Conference” to be awarded CCMC credit.
This activity is approved for 0.75 contact hour(s) ([0.075] CEU) in states that recognize ACPE.
Attending the full program will earn 0.75 contact hour(s). Unique Activity Number(s): 0860-0000-15-025-H01-P
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been pre-approved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization to which you wish you apply credit.
Method for Calculating CE Credit
CE credit was calculated by the complexity of content.
This activity is provided by OptumHealth Education.
There was no commercial support received for this activity.
To view this activity you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+, or Adobe Flash Player 9+. Be sure to disable your pop-up blocking software prior to the beginning of this activity.
This activity is designed to meet the educational needs of case managers, nurses, pharmacists, physicians and other health care professionals who are interested in type 2 diabetes.
This activity consists of recorded presentations from the "24th Annual National Conference" held in Minneapolis, MN on September 29–October 1, 2015.
- 0.75 ACPE - Pharmacist
- 0.75 AMA
- 0.75 ANCC
- 0.75 Attendance
- 0.75 CCMC - General